Orally diluting hemofiltration.

Area of Science:

• Nephrology
• Renal Replacement Therapy
• Biomedical Engineering

Background:

• Uremia presents a significant challenge in fluid and electrolyte management.
• Hemodialysis is a common but resource-intensive treatment for kidney failure.
• Novel, less invasive renal replacement therapies are needed.

Purpose of the Study:

• To introduce and evaluate a new technique called orally diluting hemofiltration (ODHF).
• To assess the feasibility of ODHF as a standalone treatment for uremic patients.

Main Methods:

• ODHF involves fluid dilution with oral electrolyte solutions and filtration via the RP-6 dialyzer.
• Two uremic patients were treated with a regimen of 5-hour ODHF sessions, three times weekly.
• One patient received ODHF for two months, and another for four months.

Main Results:

• ODHF was implemented as a novel extracorporeal purification method.
• Patients were maintained on ODHF without the need for supportive hemodialysis.
• The treatment regimen was sustained for significant durations (2 and 4 months).

Conclusions:

• Orally diluting hemofiltration (ODHF) shows promise as a viable alternative renal replacement therapy.
• This technique may reduce reliance on conventional hemodialysis.
• Further research is warranted to explore ODHF's long-term efficacy and patient outcomes.